Here’s a factoid you may not have seen coming. By 2030, the six countries of the Gulf Cooperation Council annually purchase more than $23 billion worth of products and services related to generative AI.

No time like the present to canvass experts for their opinions on which tools are tops. 

The suggestion comes from a strategic communications professional who specializes in thinking creatively about how to unlock opportunities—including those that are, at present, hard to see.

Querying 55 thought leaders behind closed doors, the Stanford Institute for Human-Centered AI has found only 12% believe healthcare AI should always have a human in the loop.

When it comes to adopting healthcare AI, large, well-off hospitals are likely to frequently homer while smaller, struggling institutions go down looking. (Baseball analogy in honor of tonight’s Midsummer Classic.) 

Using the technology and making it work for purpose are two different things. And the U.S. leads all countries in terms of full implementation, at 24% (vs. 19% for China).

Oncologists using or considering AI tools tend to agree among themselves on three points of ethics—and to recognize the same number of ways AI could help advance the state of patient care. 

Is U.S. healthcare capable of achieving its own quadruple aim? Or is that ideal destined to remain a perpetual pursuit, always chased but never really caught?